These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 26830609

  • 1. Prognostic significance of parameters from pretreatment (18)F-FDG PET in hepatocellular carcinoma: a meta-analysis.
    Sun DW, An L, Wei F, Mu L, Shi XJ, Wang CL, Zhao ZW, Li TF, Lv GY.
    Abdom Radiol (NY); 2016 Jan; 41(1):33-41. PubMed ID: 26830609
    [Abstract] [Full Text] [Related]

  • 2. Predictive value of ¹⁸F-fluorodeoxyglucose PET/CT for transarterial chemolipiodolization of hepatocellular carcinoma.
    Song MJ, Bae SH, Yoo IeR, Park CH, Jang JW, Chun HJ, Choi BG, Lee HG, Choi JY, Yoon SK.
    World J Gastroenterol; 2012 Jul 07; 18(25):3215-22. PubMed ID: 22783045
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prediction of tumor recurrence by 18F-FDG PET in liver transplantation for hepatocellular carcinoma.
    Lee JW, Paeng JC, Kang KW, Kwon HW, Suh KS, Chung JK, Lee MC, Lee DS.
    J Nucl Med; 2009 May 07; 50(5):682-7. PubMed ID: 19372474
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. 18F-FDG PET/CT Can Predict Survival of Advanced Hepatocellular Carcinoma Patients: A Multicenter Retrospective Cohort Study.
    Na SJ, Oh JK, Hyun SH, Lee JW, Hong IK, Song BI, Kim TS, Eo JS, Lee SW, Yoo IR, Chung YA, Yun M.
    J Nucl Med; 2017 May 07; 58(5):730-736. PubMed ID: 27789714
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with Barcelona Clinic Liver Cancer stages 0 and A hepatocellular carcinomas: a multicenter retrospective cohort study.
    Hyun SH, Eo JS, Lee JW, Choi JY, Lee KH, Na SJ, Hong IK, Oh JK, Chung YA, Song BI, Kim TS, Kim KS, Moon DH, Yun M.
    Eur J Nucl Med Mol Imaging; 2016 Aug 07; 43(9):1638-45. PubMed ID: 26936852
    [Abstract] [Full Text] [Related]

  • 10. [Positron emission tomography with fluorine-18-fluorodeoxyglucose is useful for predicting the prognosis of patients with hepatocellular carcinoma].
    Kong YH, Han CJ, Lee SD, Sohn WS, Kim MJ, Ki SS, Kim J, Jeong SH, Kim YC, Lee JO, Cheon GJ, Choi CW, Lim SM.
    Korean J Hepatol; 2004 Dec 07; 10(4):279-87. PubMed ID: 15613803
    [Abstract] [Full Text] [Related]

  • 11. The predictive value of metabolic tumor volume on FDG PET/CT for transarterial chemoembolization and transarterial chemotherapy infusion in hepatocellular carcinoma patients without extrahepatic metastasis.
    Lee JW, Yun M, Cho A, Han KH, Kim DY, Lee SM, Lee JD.
    Ann Nucl Med; 2015 Jun 07; 29(5):400-8. PubMed ID: 25652647
    [Abstract] [Full Text] [Related]

  • 12. Predictive Value of 18F-FDG PET/CT for Vascular Invasion in Patients With Hepatocellular Carcinoma Before Liver Transplantation.
    Lin CY, Liao CW, Chu LY, Yen KY, Jeng LB, Hsu CN, Lin CL, Kao CH.
    Clin Nucl Med; 2017 Apr 07; 42(4):e183-e187. PubMed ID: 28114226
    [Abstract] [Full Text] [Related]

  • 13. Clinical Impact of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma.
    Lee SD, Kim SH, Kim SK, Kim YK, Park SJ.
    Transplantation; 2015 Oct 07; 99(10):2142-9. PubMed ID: 25905981
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in predicting treatment response in unresectable hepatocellular carcinoma patients treated with external beam radiotherapy.
    Kim JW, Seong J, Yun M, Lee IJ, Yoon HI, Cho HJ, Han KH.
    Int J Radiat Oncol Biol Phys; 2012 Mar 01; 82(3):1172-8. PubMed ID: 21570203
    [Abstract] [Full Text] [Related]

  • 17. 18F-fluorodeoxyglucose uptake on positron emission tomography as a prognostic predictor in locally advanced hepatocellular carcinoma.
    Kim BK, Kang WJ, Kim JK, Seong J, Park JY, Kim DY, Ahn SH, Lee DY, Lee KH, Lee JD, Han KH.
    Cancer; 2011 Oct 15; 117(20):4779-87. PubMed ID: 21469082
    [Abstract] [Full Text] [Related]

  • 18. Prognostic implication of (18)F FDG-PET in patients with extrahepatic metastatic hepatocellular carcinoma undergoing systemic treatment, a retrospective cohort study.
    Shin DY, Han SW, Oh DY, Im SA, Kim TY, Bang YJ.
    Cancer Chemother Pharmacol; 2011 Jul 15; 68(1):165-75. PubMed ID: 20872146
    [Abstract] [Full Text] [Related]

  • 19. Prognostic value of 18F-FDG PET for hepatocellular carcinoma patients treated with sorafenib.
    Lee JH, Park JY, Kim DY, Ahn SH, Han KH, Seo HJ, Lee JD, Choi HJ.
    Liver Int; 2011 Sep 15; 31(8):1144-9. PubMed ID: 21745288
    [Abstract] [Full Text] [Related]

  • 20. [Diagnostic accuracy of 18F-FDG positron emission tomography for evaluation of hepatocellular carcinoma].
    Shin JA, Park JW, An M, Choi JI, Kim SH, Kim SK, Lee WJ, Park SJ, Hong EK, Kim CM.
    Korean J Hepatol; 2006 Dec 15; 12(4):546-52. PubMed ID: 17237633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.